Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.8057
+0.0087 (1.09%)
At close: Jun 5, 2025, 4:00 PM
0.7900
-0.0157 (-1.95%)
After-hours: Jun 5, 2025, 4:39 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Human Pharmaceutical Products
257.24M
Log In
Log In
Log In
Log In
Upgrade
Human Pharmaceutical Products Growth
21.89%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
257.24M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
21.89%
Log In
Log In
Log In
Log In
Upgrade